Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 4,301–4,350 of 4,691 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06736054	A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer	recruiting	Phase 1	8	Hoag Memorial Hospital PresbyterianOTHER	1	Dec 16, 2024	clinicaltrials
NCT04278287	Chemoradiotherapy in Unresectable Esophageal Cancer	recruiting	Phase 1 / Phase 2	105	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1	Dec 13, 2024	clinicaltrials